Russia`s leading pharmaceutical Group committed to development and manufacture of advanced, high-quality, affordable medicines that meet the healthcare requirements and patients’ expectations.

  • pharmaceutical products

  • new products

  • essential drugs


“Development and manufacture of advanced pharmaceutical products compliant with the healthcare requirements and patients’ expectations”
Pharmstandard Group manufactures medicines of various pharmacotherapeutic groups, including those for treatments of cardiovascular diseases, diabetes, growth hormone deficiency, gastroenterological, neurological, contagious diseases, metabolic disorders, cancer and other diseases.

The Company’s total manufacturing capacity exceeds 1.7 bln. packs per year. Pharmstandard Group’s manufacturing facilities comprise 5 state-of-the-art pharmaceutical plants:
  • GMP and ISO quality standards

  • state-of-the-art plants

  • packs per year

Pharmstandard LLC (Moscow) manages raw material purchase and supply to ensure subsequent manufacturing of pharmaceutical products at Pharmstandard Group facilities.

PHS-Tomskhimpharm JSC
The largest manufacturer of finished pharmaceutical products in Western Siberia. GMP-certified since 2010. The Company celebrated its 80th anniversary in 2016.
Pharmstandard-UfaVITA JSC
One of the largest pharmaceutical manufacturers in Russia. Apart from vitamins, the Company manufactures a wide range of medicines of other pharmacotherapeutic groups. At present its portfolio includes more than 100 product names.
Phs-Leksredstva JSC
The Company ranks in the top-5 largest pharmaceutical manufacturers in Russia and actively participates in the state import substitution program. Manufacturing capacity: over 500 mln. packs per year



All the Group manufacturing facilities fully comply with the Russian standards. Phs-Leksredstva JSC and Pharmstandard-UfaVITA JSC production sites are EU GMP-certified.

All the Group manufacturing facilities fully comply with the Russian standards. Phs-Leksredstva JSC and Pharmstandard-UfaVITA JSC production sites have obtained the certificates of compliance with the international standards. At Phs-Leksredstva JSC 6 production lines are EU GMP-certified. By the Group management adoption there is a program in place to convert all the plants to the European GMP standards.
Social Responsibility

In its operations the Group is committed to the following fundamental principles:

Innovation — immediate implementation of cutting-edge developments in medicine and pharmacology in close cooperation with Russian and international scientists.
Efficiency — business process management, based on an efficient and balanced combination of scientific-technical innovations and extensive expertise gained by the Group over the years of sound activities in the pharmaceutical market.
Responsibility — application of international management and process standards as part of the Group responsibility to the customer. Compliance with environmental standards and reduction of industrial impact on the environment in the context of responsibility to future generations.

Strategic Development Areas of the Group

Development and introduction of new products, extension of the formulation range and dosage forms in order to meet market demand and customers expectations to the maximum.

Enhancement of manufacturing localization through joint projects with leading foreign pharmaceutical companies

Extension of Group's product portfolio with high-margin pharmaceuticals

Increase of Group's participation in the state import substitution program

Automation of production planning processes in order to increase efficiency of process management and strengthen cost control

Within the frames of its strategic development the Group invests heavily in development and upgrade of its manufacturing facilities.

Pharmstandard Group, the undisputed leader in Russian Pharma Manufacturing, guarantees the highest quality standards of the manufactured pharmaceuticals to its customers. The underlying principles of Pharmstandard social policy have been brought into line with Russia`s national policy of medicine procurement, stipulating substitution of expensive imported pharmaceuticals with affordable local products manufactured in compliance with the highest international standards.

Pharmstandard is known for its commitment to product safety and efficacy. To take up these challenges, the Group has implemented a rigorous internal system of pharmacovigilance aimed at collection and analysis of information on adverse events and drug interactions, as well as effective coordination with the relevant regulatory authorities.

Being highly socially responsible, Pharmstandard provides focused support to vulnerable social groups and social welfare institutions on a regular basis.

The Group highly appreciates doctors` and patients’ trust in the pharmaceuticals manufactured under Pharmstandard trademark and continuously invests in development of new products and refinement of manufacturing technologies.

5B, Likhachyovsky Proezd, Dolgoprudny, Moscow Region, 141701, Russia

+7 (495) 970 0030/32


© 2007–2017

All rights reserved. JSC Pharmstandard.
Terms of use Disclosure of information.


Информация на сайте предназначена исключительно для медицинских работников.

Подтвердите, пожалуйста, являетесь ли Вы медицинским работником.

Если Вы не являетесь медицинским работником, пожалуйста, покиньте данный раздел сайта.


1.На сайте представлена информация о рецептурных препаратах, их свойствах, способах применения и возможных противопоказаниях исключительно специалистам здравоохранения (лицам, имеющим высшее или среднее специальное медицинское образование).

2. Если Вы являетесь специалистом здравоохранения и хотите получить информацию с данного раздела сайта, Вам необходимо подтвердить ваш статус специалиста здравоохранения.

3. В случае если Вы не являетесь специалистом здравоохранения, но в нарушение настоящих условий подписываете данное соглашение, сайт Компании не несет ответственности за возможные отрицательные последствия, возникшие в результате самостоятельного использования Вами информации с сайта, без предварительной консультации со специалистом. Вы делаете это самостоятельно и осознанно, понимая, что применение рецептурных препаратов возможно только после предварительной консультации со специалистом здравоохранения.

4. Информация о рецептурных препаратах, представленная на данном разделе сайте, предназначена исключительно для ознакомления с препаратами и не является руководством для самостоятельной диагностики или лечения, и не служит в качестве медицинских советов или рекомендаций. Сайт не несет ответственности за возможный ущерб, нанесенный Вашему здоровью в случае самовольного лечения, проводимого на основании применения рецептурных препаратов (без предварительной консультации со специалистом). Настоящим я подтверждаю, что являюсь специалистом здравоохранения и подтверждаю своё согласие с тем, что применение рецептурных препаратов возможно только после предварительной консультации со специалистом.